Hedge Fund Takes On Toughest ESG Market With Long-Short Bet
A European ESG classification that’s proved too strict for many of the world’s biggest asset managers has just been embraced by a hedge fund manager in London.
Bloomberg Business
Canaccord Managers Try to Take Firm Private After Stock Drop
Canaccord Genuity Group Inc.’s management group is seeking to take the firm private in a C$1.13 billion ($843 million) deal, taking advantage of a plunge in the share price after last year’s turmoil in capital markets.
FanDuel Plans $10 Million Promotion in First Super Bowl Spot
FanDuel’s first Super Bowl ad will feature a live field goal kicked by former NFL star Rob Gronkowski, an attention-grabbing move aimed at extending its lead in the US sports betting market.
Estonia to Move Ahead of EU With Plans to Seize Russian Assets
Estonia plans to introduce a legal blueprint for seizing Russian assets this month as the Baltic nation moves ahead with a bid to deliver funds frozen under European Union sanctions to Ukraine.
Egypt’s Currency Drop Barely Closes Gap With Black Market Rate
The Egyptian currency slid to a new record but remains far stronger than rates quoted in the black market, underscoring the risk of further depreciation as the North African nation grapples with a foreign-exchange crunch.
Lululemon Tumbles After Lowering Profitability Forecast
Lululemon Athletica Inc. shares tumbled after the maker of fitness wear lowered its guidance for gross margin, stoking fears about profitability for a second-straight quarter.
Vista Equity to Pay $2.6 Billion for the Insurtech Duck Creek
Vista Equity Partners agreed to pay about $2.6 billion in cash for insurance technology provider Duck Creek Technologies Inc.
Ford to Partner With LG on Turkey Battery Plant, Drops SK
Ford Motor Co. will partner with LG Energy Solution Ltd. to build a new battery plant in Turkey, dropping a deal with SK On Co., as the US carmaker seeks to speed up the shift to clean cars and diversify its battery suppliers, people familiar with the matter said.
CVS Says 2022 Revenue Beat Guidance in Preliminary Results
CVS Health Corp. said its revenue for all of fiscal 2022 exceeded its guidance that topped out at $314 billion.
AstraZeneca to Buy CinCor Pharma for Up to $1.8 Billion
AstraZeneca Plc agreed to buy US biotech CinCor Pharma Inc. for as much as $1.8 billion to gain a promising new treatment for hypertension and kidney disease.
